Azathioprine in the treatment of pemphigus vulgaris: A long-term follow-up

Journal of the American Academy of Dermatology

Volumn 16, Issue 3, 1987, Pages 527-533

  Aberer, Werner ^a   Wolff Schreiner, Elisabeth C ^a   Stingl, Georg ^a   Wolff, Klaus ^a  

^a UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PEMPHIGUS ANTIBODY; PREDNISONE; TRIAMCINOLONE;

ADVERSE DRUG REACTION; BLOOD AND HEMOPOIETIC SYSTEM; BONE; CARDIOVASCULAR SYSTEM; CATARACT; CLINICAL ARTICLE; CUSHINGOID SYNDROME; DIABETES MELLITUS; DIGESTIVE SYSTEM; DRUG EFFICACY; DRUG THERAPY; EFFICACY; ENDOCRINE SYSTEM; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; HYPERTENSION; INTOXICATION; LEUKOPENIA; LUNG TUBERCULOSIS; ORAL DRUG ADMINISTRATION; OSTEOPOROSIS; PEMPHIGUS VULGARIS; PEPTIC ULCER; PRIORITY JOURNAL; RESPIRATORY SYSTEM; SAFETY; THERAPY; VISUAL SYSTEM;

AGED; AUTOANTIBODIES; AZATHIOPRINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS, SYNTHETIC; HUMAN; MALE; MIDDLE AGE; PEMPHIGUS; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0023148121     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(87)70069-3     Document Type: Article

References (37)

1. Treatment of pemphigus with corticosteroids: study of 52 patients
2. Corticosteroid treatment of pemphigus
3. Treatment in bullous diseases with corticosteroid drugs and corticotrophin
4. Treatment of pemphigus with corticosteroids. Results obtained in 46 patients over a period of 11 years
5. Pemphigus: a 24-year survey of experience with 70 cases
6. International mortality from bullous diseases since 1950
7. The immunopathoiogy of pemphigus and bullous pemphigoid
8. Immunosuppressive therapy for pemphigus vulgaris
9. Pemphigus vulgaris successfully treated with cyclophosphamide
10. Treatment of pemphigus vulgaris with methotrexate
11. Immunosuppressive Therapie bullöser Dermatosen
12. Management of pemphigus with gold compounds: a long-term follow-up report
13. Antiproliferative agents and drugs used for immunosuppression
14. A collaborative UK-Australasian study of cancer in patients treated with immunosuppressive drugs
15. Immunosuppressants in the treatment of pemphigus
16. Pemphigus treatment with azathioprine
17. Treatment of pemphigus and pemphigoid with azathioprine
18. Azathioprine in pemphigus and pemphigoid: a four-year study follow-up
19. Treatment of pemphigus vulgaris
20. Adjuvant therapy of pemphigus
21. Use of cytotoxic drugs in dermatologic diseases. II
22. Successful use of cyclophosphamide and prednisone for initial treatment of pemphigus vulgaris
23. Cytotoxic drugs in treatment of nonmalignant diseases
24. Pemphigus and pemphigoid
25. Plasma exchange in pemphigus
26. Effects of cyclosporine on bullous pemphigoid and pemphigus
27. Pemphigus vulgaris—maligner Verlauf
28. Failure of cytotoxic durgs to suppress immune reponses of patients with rheumatoid arthritis
29. Long-term maintenance therapy with azathioprine in systemic lupus erythematosus
30. Possible usefulness of azathioprine (Imuran) in severe rheumatoid arthritis
31. Immunosuppressive therapy and cancer
32. Risk of cancer in renal transplant recipients
33. Oncogenicity of immunosuppressive drugs
34. Acute myelogenous leukemia in two patients treated with azathioprine for nonmalignant diseases
35. Death in pemphigus
36. The events leading to the death of patients with pemphigus and pemphigoid